Rossari Historical Income Statement

ROSSARI Stock

796.95 3.50 0.44%

Historical analysis of Rossari Biotech income statement accounts such as Other Operating Expenses of 9 B, Operating Income of 1.1 B, EBIT of 1.1 B or Research Development of 63 M can show how well Rossari Biotech Limited performed in making a profits. Evaluating Rossari Biotech income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Rossari Biotech's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Rossari Biotech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Rossari Biotech is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rossari Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Rossari Income Statement Analysis

Rossari Biotech Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Rossari Biotech shareholders. The income statement also shows Rossari investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Rossari Biotech Income Statement Chart

As of now, Rossari Biotech's Minority Interest is increasing as compared to previous years.

Total Revenue Gross Profit Other Operating Expenses Operating Income Income Before Tax Minority Interest

Total Revenue

Total revenue comprises all receipts Rossari Biotech generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Rossari Biotech Limited minus its cost of goods sold. It is profit before Rossari Biotech operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Rossari Biotech. It is also known as Rossari Biotech overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Rossari Biotech operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Rossari Biotech Limited is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Rossari Biotech income statement and is an important metric when analyzing Rossari Biotech profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Minority Interest

Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Rossari Biotech Limited whose combined shares represent less than 50% of the total outstanding shares issued by Rossari Biotech have a minority interest in Rossari Biotech.

Most accounts from Rossari Biotech's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Rossari Biotech current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rossari Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

As of now, Rossari Biotech's Minority Interest is increasing as compared to previous years.

	2021	2022	2023	2024 (projected)
Interest Expense	126.6M	223.2M	193.7M	203.4M
Depreciation And Amortization	480.6M	629.3M	603.9M	320.0M

Interest Expense Depreciation And Amortization

Rossari Biotech income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Tax Provision	Net Interest Income	Interest Income	Selling General Administrative	Selling And Marketing Expenses	Net Income From Continuing Ops	Reconciled Depreciation
Depreciation And Amortization		0.92	1.0	0.95	1.0	0.96	0.96	0.82	0.98	0.9	0.84	0.95	-0.71	0.95	0.95	0.97	-0.94	0.78	0.99	0.95	0.96	1.0
Interest Expense	0.92		0.91	0.85	0.91	0.86	0.84	0.75	0.87	0.96	0.93	0.84	-0.57	0.84	0.83	0.88	-1.0	0.62	0.91	0.88	0.87	0.93
Total Revenue	1.0	0.91		0.94	1.0	0.97	0.97	0.78	0.99	0.91	0.85	0.97	-0.66	0.96	0.97	0.98	-0.93	0.78	0.99	0.96	0.97	0.99
Gross Profit	0.95	0.85	0.94		0.93	0.94	0.93	0.8	0.94	0.83	0.77	0.94	-0.79	0.94	0.94	0.92	-0.88	0.81	0.92	0.96	0.93	0.95
Other Operating Expenses	1.0	0.91	1.0	0.93		0.97	0.96	0.78	0.98	0.91	0.85	0.96	-0.67	0.96	0.96	0.98	-0.93	0.78	0.99	0.95	0.97	0.99
Operating Income	0.96	0.86	0.97	0.94	0.97		1.0	0.79	1.0	0.89	0.86	1.0	-0.6	1.0	0.99	0.98	-0.88	0.83	0.95	0.97	0.99	0.96
Ebit	0.96	0.84	0.97	0.93	0.96	1.0		0.78	1.0	0.89	0.86	1.0	-0.58	1.0	1.0	0.99	-0.86	0.85	0.96	0.96	0.99	0.95
Research Development	0.82	0.75	0.78	0.8	0.78	0.79	0.78		0.8	0.72	0.67	0.79	-0.7	0.8	0.75	0.8	-0.77	0.8	0.82	0.77	0.83	0.82
Ebitda	0.98	0.87	0.99	0.94	0.98	1.0	1.0	0.8		0.9	0.86	1.0	-0.62	1.0	0.99	0.99	-0.89	0.83	0.97	0.97	0.99	0.97
Cost Of Revenue	0.9	0.96	0.91	0.83	0.91	0.89	0.89	0.72	0.9		0.98	0.88	-0.46	0.88	0.88	0.92	-0.96	0.72	0.92	0.88	0.91	0.91
Total Operating Expenses	0.84	0.93	0.85	0.77	0.85	0.86	0.86	0.67	0.86	0.98		0.85	-0.32	0.85	0.85	0.88	-0.92	0.65	0.85	0.86	0.88	0.86
Income Before Tax	0.95	0.84	0.97	0.94	0.96	1.0	1.0	0.79	1.0	0.88	0.85		-0.6	1.0	1.0	0.99	-0.86	0.86	0.95	0.97	0.99	0.95
Total Other Income Expense Net	-0.71	-0.57	-0.66	-0.79	-0.67	-0.6	-0.58	-0.7	-0.62	-0.46	-0.32	-0.6		-0.6	-0.6	-0.59	0.6	-0.65	-0.68	-0.62	-0.59	-0.7
Net Income	0.95	0.84	0.96	0.94	0.96	1.0	1.0	0.8	1.0	0.88	0.85	1.0	-0.6		0.99	0.98	-0.86	0.86	0.95	0.97	0.99	0.95
Income Tax Expense	0.95	0.83	0.97	0.94	0.96	0.99	1.0	0.75	0.99	0.88	0.85	1.0	-0.6	0.99		0.98	-0.86	0.85	0.95	0.96	0.99	0.95
Tax Provision	0.97	0.88	0.98	0.92	0.98	0.98	0.99	0.8	0.99	0.92	0.88	0.99	-0.59	0.98	0.98		-0.9	0.85	0.98	0.95	0.99	0.97
Net Interest Income	-0.94	-1.0	-0.93	-0.88	-0.93	-0.88	-0.86	-0.77	-0.89	-0.96	-0.92	-0.86	0.6	-0.86	-0.86	-0.9		-0.65	-0.93	-0.89	-0.89	-0.95
Interest Income	0.78	0.62	0.78	0.81	0.78	0.83	0.85	0.8	0.83	0.72	0.65	0.86	-0.65	0.86	0.85	0.85	-0.65		0.83	0.75	0.86	0.78
Selling General Administrative	0.99	0.91	0.99	0.92	0.99	0.95	0.96	0.82	0.97	0.92	0.85	0.95	-0.68	0.95	0.95	0.98	-0.93	0.83		0.92	0.97	0.99
Selling And Marketing Expenses	0.95	0.88	0.96	0.96	0.95	0.97	0.96	0.77	0.97	0.88	0.86	0.97	-0.62	0.97	0.96	0.95	-0.89	0.75	0.92		0.96	0.95
Net Income From Continuing Ops	0.96	0.87	0.97	0.93	0.97	0.99	0.99	0.83	0.99	0.91	0.88	0.99	-0.59	0.99	0.99	0.99	-0.89	0.86	0.97	0.96		0.96
Reconciled Depreciation	1.0	0.93	0.99	0.95	0.99	0.96	0.95	0.82	0.97	0.91	0.86	0.95	-0.7	0.95	0.95	0.97	-0.95	0.78	0.99	0.95	0.96

Click cells to compare fundamentals

Rossari Biotech Account Relationship Matchups

Rossari Biotech income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	168.5M	228.3M	480.6M	629.3M	603.9M	320.0M
Interest Expense	35.6M	29.9M	126.6M	223.2M	193.7M	203.4M
Total Revenue	6.0B	7.1B	14.8B	16.6B	18.3B	10.0B
Gross Profit	2.2B	2.3B	3.6B	4.8B	3.2B	2.6B
Other Operating Expenses	5.1B	6.1B	13.5B	15.0B	16.4B	9.0B
Operating Income	879.6M	1.0B	1.3B	1.5B	1.8B	1.1B
Ebit	916.2M	1.1B	1.5B	1.5B	2.0B	1.1B
Research Development	53.5M	75.0M	59.5M	82.6M	70.2M	63.0M
Ebitda	1.1B	1.3B	1.9B	2.1B	2.6B	1.4B
Cost Of Revenue	3.8B	4.8B	11.1B	11.7B	15.1B	15.9B
Total Operating Expenses	1.3B	1.3B	2.3B	3.2B	5.2B	5.5B
Income Before Tax	878.4M	1.1B	1.4B	1.4B	1.8B	1.1B
Total Other Income Expense Net	(13.4M)	(847.6M)	(1.6B)	(2.2B)	(51.0M)	(53.6M)
Net Income Applicable To Common Shares	456.8M	652.5M	802.2M	976.7M	1.1B	602.3M
Net Income	652.5M	802.2M	976.7M	1.1B	1.3B	778.9M
Income Tax Expense	225.9M	267.9M	385.8M	369.6M	469.3M	283.3M
Tax Provision	225.9M	267.9M	385.8M	369.6M	469.3M	316.8M
Net Interest Income	(20.1M)	(29.9M)	(126.6M)	(223.2M)	(193.7M)	(184.0M)
Interest Income	15.4M	42.7M	40.7M	25.2M	29.0M	24.9M
Selling General Administrative	57.1M	84.2M	151.2M	153.4M	169.7M	107.3M
Selling And Marketing Expenses	407.9M	308.7M	511.2M	666.7M	643.6M	467.4M
Net Income From Continuing Ops	652.5M	800.5M	977.0M	1.1B	1.3B	867.5M
Reconciled Depreciation	168.5M	228.3M	480.6M	629.3M	603.9M	359.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Other Information on Investing in Rossari Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Rossari Historical Income Statement

About Rossari Income Statement Analysis

Rossari Biotech Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Operating Income

Income Before Tax

Minority Interest

Rossari Biotech income statement Correlations

Rossari Biotech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Rossari Biotech income statement Accounts

Also Currently Popular

Other Information on Investing in Rossari Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Revenue	+ 1.0	Depreciation And Amortization
Other Operating Expenses	+ 1.0	Depreciation And Amortization
Reconciled Depreciation	+ 1.0	Depreciation And Amortization
Other Operating Expenses	+ 1.0	Total Revenue
Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Operating Income

Net Interest Income	- 1.0	Interest Expense
Net Interest Income	- 0.96	Cost Of Revenue
Reconciled Depreciation	- 0.95	Net Interest Income
Net Interest Income	- 0.94	Depreciation And Amortization
Selling General Administrative	- 0.93	Net Interest Income
Net Interest Income	- 0.93	Other Operating Expenses